Yikilmaz, Taha Numan, et al. “Clinical Use of Tumor Markers for the Detection and Prognosis of Bladder Carcinoma: A Comparison of CD44, Cytokeratin 20 and Survivin”. Urology Journal, vol. 13, no. 3, June 2016, pp. 2677-83, doi:10.22037/uj.v13i3.3294.